from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3366/spoU

LFCtreatmentdescriptionclass of inhibitor

-1.038

Amikacinug/mL Amikacintranslation

-0.595

Cap5-10ug/mL Capreomycintranslation

-0.370

Rox10-50 ug/mL Roxithromycintranslation

-0.504

SM2-5 ug/mL Streptomycintranslation

-1.971

Tet5-10 ug/mL Tetracyclinetranslation

1.099

Rif0.2-5ug/mL Rifampicintranscription

0.422

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.889

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.058

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.048

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.103

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.067

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.203

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.309

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.818

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.151

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.047

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.079

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.581

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.721

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.576

Nigericin50 uM Nigericinrespiration

0.836

TRC10-150 ug/mL Triclosanrespiration

1.032

TRZ10-25 ug/mL Thioridazinerespiration

0.323

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.340

menadione6-10 ug/mL Menadionerespiration

-0.132

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.789

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.393

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.907

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.114

NRP_1Non-replicating persistence stage 1dosRassociated

-1.402

Amp0.2mg/mL AmpicillincellWall

-0.282

Cephalexin20-100 ug/mL CephalexincellWall

0.356

Cerulenin0.32-5 ug/mL CerulenincellWall

0.289

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.034

EMB10-20 ug/mL EthambutolcellWall

-1.119

Eta12-40 ug/mL EthionamidecellWall

-1.467

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.486

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.287

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.125

BZA0.12 mg/mL BenzamidearomaticAmides

0.342

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.423

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.517

H2O24 mM hydrogen peroxideDNAdamaging

-0.493

Levo10 ug/mL LevofloxacinDNAdamaging

0.352

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.643

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.080

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.033

UVUV-irradiationDNAdamaging

0.997

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.534

Antimycin12.5-50 ug/mL Antimycin A?

-0.404

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.327

PA_110-50 ug/mL Antitubercular compound PA-1?

0.373

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.119

PA8240.2-2 ug/mL PA-824?

-0.109

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.025

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.552

Verapamil50 uM Verapamil?

0.046

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.126

methoxatin10-20 ug/mL Methoxatin?